173 related articles for article (PubMed ID: 38443650)
1. Increased Nasal Blimp1 + Treg Cells After Sublingual Immunotherapy Reflect the Efficacy of Treatment in Allergic Rhinitis.
Pan Y; Zhang X; Geng H; Yu Y; Liu J; Li M; Yang H; Yuan Y; Xu Y; Wu Y; Wu G; Ma X; Cheng L
Adv Ther; 2024 Apr; 41(4):1698-1710. PubMed ID: 38443650
[TBL] [Abstract][Full Text] [Related]
2. Role of leptin in allergic rhinitis during sublingual immunotherapy.
Wen Y; Zhou L; Li Y; Li Z; Deng W; Zhang T
Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2733-2738. PubMed ID: 30218387
[TBL] [Abstract][Full Text] [Related]
3. Role of BAFF in pediatric patients with allergic rhinitis during sublingual immunotherapy.
Luo R; Liu W; Wang J; Chen Y; Sun C; Zhou L; Li Y; Deng L
Eur J Pediatr; 2014 Aug; 173(8):1033-40. PubMed ID: 24585100
[TBL] [Abstract][Full Text] [Related]
4. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
[TBL] [Abstract][Full Text] [Related]
5. Immune Cell Alterations and PI3K-PKB Pathway Suppression in Patients with Allergic Rhinitis Undergoing Sublingual Immunotherapy.
Zhang X; Wu G; Ma X; Cheng L
Adv Ther; 2024 Feb; 41(2):777-791. PubMed ID: 38169061
[TBL] [Abstract][Full Text] [Related]
6. The influence of house dust mite sublingual immunotherapy on the TSLP-OX40L signaling pathway in patients with allergic rhinitis.
Meng Q; Liu X; Li P; He L; Xie J; Gao X; Wu X; Su F; Liang Y
Int Forum Allergy Rhinol; 2016 Aug; 6(8):862-70. PubMed ID: 27012942
[TBL] [Abstract][Full Text] [Related]
7. Serum Soluble ST2 Correlated with Symptom Severity and Clinical Response of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis Patients.
Zhu K; Xia C; Chen J; Yu C; Gao T; Yan J; Shao N; Zhu P; Sun B; Ren X; Zhang Y
Mediators Inflamm; 2021; 2021():5576596. PubMed ID: 34194284
[TBL] [Abstract][Full Text] [Related]
8. [The efficacy of sublingual specific immunotherapy in children with allergic rhinitis].
Li P; Fa M; Huang ZH; Xie LS; Xu Y; Chen WB; Zhang JY; Zhang XR; Zhu Z; Li Q
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 30(7):546-551. PubMed ID: 29871066
[No Abstract] [Full Text] [Related]
9. Increase in the prevalence of follicular regulatory T cells correlates with clinical efficacy of sublingual immunotherapy with house dust mites.
Murao T; Kouzaki H; Arai H; Matsumoto K; Nakamura K; Kawakita K; Tojima I; Shimizu S; Yuta A; Shimizu T
Int Forum Allergy Rhinol; 2024 Jan; 14(1):57-67. PubMed ID: 37345377
[TBL] [Abstract][Full Text] [Related]
10. The Role of Nasal Endoscopy in Allergic Rhinitis and House Dust Mite Sublingual Immunotherapy.
Liu B; Feng J; Hu S
Int Arch Allergy Immunol; 2021; 182(8):690-696. PubMed ID: 34000723
[TBL] [Abstract][Full Text] [Related]
11. Serum Periostin as a Biomarker for Predicting Clinical Response to House Dust Mite Sublingual Immunotherapy in Allergic Rhinitis.
Hoshino M; Akitsu K; Kubota K; Ohtawa J
J Allergy Clin Immunol Pract; 2021 May; 9(5):1864-1870. PubMed ID: 33290915
[TBL] [Abstract][Full Text] [Related]
12. Changes in type 2 innate lymphoid cells and serum cytokines in sublingual immunotherapy in pediatric patients with allergic rhinitis.
Wang X; Shen Y; Hong S; Kang H; Ke X
BMC Pediatr; 2023 Jan; 23(1):13. PubMed ID: 36624390
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of efficacy of 1 year after completing the 2-year specific sublingual immunotherapy treatment course in allergic rhinitis].
Han L; You QJ; Li Z; Yang HH; Fang H; Zhang Y
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jul; 52(7):497-500. PubMed ID: 28728237
[No Abstract] [Full Text] [Related]
14. Changes in CD4+CD25+FoxP3+ Regulatory T Cells and Serum Cytokines in Sublingual and Subcutaneous Immunotherapy in Allergic Rhinitis with or without Asthma.
Xian M; Feng M; Dong Y; Wei N; Su Q; Li J
Int Arch Allergy Immunol; 2020; 181(1):71-80. PubMed ID: 31722337
[TBL] [Abstract][Full Text] [Related]
15. Nasal microbes in allergic rhinitis children with or without sublingual immunotherapy.
Shen XF; Teng ZP; Li Q; Yu ZK
Medicine (Baltimore); 2023 Oct; 102(43):e35711. PubMed ID: 37904472
[TBL] [Abstract][Full Text] [Related]
16. Real-world, long-term effectiveness of allergy immunotherapy in allergic rhinitis: Subgroup analyses of the REACT study.
Contoli M; Porsbjerg C; Buchs S; Larsen JR; Freemantle N; Fritzsching B
J Allergy Clin Immunol; 2023 Aug; 152(2):445-452.e4. PubMed ID: 36871918
[TBL] [Abstract][Full Text] [Related]
17. House dust mite sublingual immunotherapy in allergic rhinitis.
Cho SW; Han DH; Kim JW; Kim DY; Rhee CS
Immunotherapy; 2018 Jun; 10(7):567-578. PubMed ID: 29562802
[TBL] [Abstract][Full Text] [Related]
18. Circulating MMP-12 as Potential Biomarker in Evaluating Disease Severity and Efficacy of Sublingual Immunotherapy in Allergic Rhinitis.
Zhou Y; Xu M; Gong W; Kang X; Guo R; Wen J; Zhou D; Wang M; Shi D; Jing Q
Mediators Inflamm; 2022; 2022():3378035. PubMed ID: 35733520
[TBL] [Abstract][Full Text] [Related]
19. Single-allergen sublingual immunotherapy versus multi-allergen subcutaneous immunotherapy for children with allergic rhinitis.
Wang ZX; Shi H
J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):407-411. PubMed ID: 28585143
[TBL] [Abstract][Full Text] [Related]
20. Sublingual Immunotherapy Decreases Expression of Interleukin-33 in Children with Allergic Rhinitis.
Wang Y; Li C; Xu Y; Xu D; Yang G; Liao F; Luo X
Indian J Pediatr; 2018 Oct; 85(10):872-876. PubMed ID: 29790007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
